AU611145B2 - Method for the treatment or prophylaxis of asthma - Google Patents

Method for the treatment or prophylaxis of asthma Download PDF

Info

Publication number
AU611145B2
AU611145B2 AU15190/88A AU1519088A AU611145B2 AU 611145 B2 AU611145 B2 AU 611145B2 AU 15190/88 A AU15190/88 A AU 15190/88A AU 1519088 A AU1519088 A AU 1519088A AU 611145 B2 AU611145 B2 AU 611145B2
Authority
AU
Australia
Prior art keywords
treatment
asthma
compound
patient
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15190/88A
Other languages
English (en)
Other versions
AU1519088A (en
Inventor
Yasushi Abiko
Kinya Kameda
Setsuo Kobayashi
Tsugio Nakazawa
Yasumasa Yoshie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU1519088A publication Critical patent/AU1519088A/en
Application granted granted Critical
Publication of AU611145B2 publication Critical patent/AU611145B2/en
Assigned to DAIICHI PHARMACEUTICAL CO., LTD. reassignment DAIICHI PHARMACEUTICAL CO., LTD. Amend patent request/document other than specification (104) Assignors: DAIICHI SEIYAKU CO. LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU15190/88A 1987-04-27 1988-04-27 Method for the treatment or prophylaxis of asthma Ceased AU611145B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62-103727 1987-04-27
JP10372787 1987-04-27

Publications (2)

Publication Number Publication Date
AU1519088A AU1519088A (en) 1988-10-27
AU611145B2 true AU611145B2 (en) 1991-06-06

Family

ID=14361688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15190/88A Ceased AU611145B2 (en) 1987-04-27 1988-04-27 Method for the treatment or prophylaxis of asthma

Country Status (15)

Country Link
US (1) US4874772A (enExample)
EP (1) EP0288978B1 (enExample)
KR (1) KR880012228A (enExample)
AT (1) ATE81974T1 (enExample)
AU (1) AU611145B2 (enExample)
CA (1) CA1309027C (enExample)
DE (1) DE3875647T2 (enExample)
DK (1) DK226688A (enExample)
ES (1) ES2052634T3 (enExample)
GR (1) GR3006610T3 (enExample)
HU (1) HU203665B (enExample)
IL (1) IL86151A (enExample)
NO (1) NO881798L (enExample)
PH (1) PH24155A (enExample)
ZA (1) ZA882737B (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤

Also Published As

Publication number Publication date
AU1519088A (en) 1988-10-27
KR880012228A (ko) 1988-11-26
DE3875647T2 (de) 1993-03-18
US4874772A (en) 1989-10-17
EP0288978A3 (en) 1990-02-21
NO881798D0 (no) 1988-04-25
PH24155A (en) 1990-03-22
DE3875647D1 (de) 1992-12-10
DK226688D0 (da) 1988-04-26
EP0288978B1 (en) 1992-11-04
DK226688A (da) 1988-10-28
HUT46537A (en) 1988-11-28
EP0288978A2 (en) 1988-11-02
CA1309027C (en) 1992-10-20
HU203665B (en) 1991-09-30
ES2052634T3 (es) 1994-07-16
IL86151A0 (en) 1988-11-15
ATE81974T1 (de) 1992-11-15
IL86151A (en) 1993-04-04
NO881798L (no) 1988-10-28
ZA882737B (en) 1988-10-17
GR3006610T3 (enExample) 1993-06-30

Similar Documents

Publication Publication Date Title
US4302471A (en) Method of treating cardiac and renal failures
Mark et al. Intraoperative awareness and hypertensive crisis during high-dose fentanyl-diazepam-oxygen anesthesia
JPH0575729B2 (enExample)
US4874772A (en) Antiasthmatic agent
EP0540738A1 (en) Remedy for sleep apnea
Anderson Hemodynamic and non-bronchial effects of ipratropium bromide
CA2335280C (en) Method of treating pulmonary hypertension
Crowe et al. A comparative study of a new selective beta 2‐adrenoceptor agonist, procaterol and salbutamol in asthma.
EP0156163A1 (en) Pharmaceutical product for the treatment of hypertension and thromboembolic diseases
EP1401450B1 (en) Use of a pyridazinone derivative for the treatment of congestive heart failure
US3932652A (en) Antidepressant compositions
JPH01131114A (ja) 心臓疾患治療剤
US7485642B2 (en) Method for treating septic shock
EP1191935A1 (en) A method for the treatment or prevention of coronary graft vasospasm
Dyson et al. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction
US4388320A (en) 3-Aminopropoxyaryl derivative in the treatment of tremor
JPH0245603B2 (enExample)
HU201244B (en) Process for production of medical compositions containing as active substance derivatives of quinoline applicable for treatment of heart-arithmia
JP2003512328A5 (enExample)
Maesen et al. Formoterol suspension aerosol: comparison with formoterol solution aerosol for 12 weeks in asthmatic patients
Petrick et al. Interaction between warfarin and ethacrynic acid
GB2173399A (en) Compositions containing 3-aminopropoxy-indoles for treating hypertension
JPS6360926A (ja) 感冒薬
Butt Recovery time after ultrabrief anaesthesia-a comparison of four techniques
DE3602304A1 (de) Pharmazeutische zubereitungen enthaltend gegebenenfalls mit einem diuretikum kombinierte 3-aminopropoxy-indole und ihre verwendung